Bacterial epidemiology and attributable mortality of Ventilator-associated pneumonia before and after COVID-19 pandemic (2018-2021)
Journal of Intensive Care Medicine · 29.10.2026
DOI: 10.1177/08850666261490896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intensive Care Medicine, online erschienen am 29.10.2026. Verfasst von Charles Hervé Vacheron und 7 weiteren Autor:innen. Beteiligte Einrichtung: Public Health, Epidemiology & Evolutionary Ecology of Infectious Diseases (PHE3ID) Team, Centre International de Recherche en Infectiologie (CIRI), I…. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Merck Sharp and Dohme France.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Background
Ventilator-associated pneumonia (VAP) is a leading cause of morbidity and mortality in mechanically ventilated patients. The COVID-19 pandemic has profoundly modified VAP epidemiology and microbial ecology.
Methods
We conducted a prospective multicenter cohort study within the REA-REZO network (≈20% of French ICU beds), 1 January 2018–31 December 2021. All adults receiving invasive mechanical ventilation were included. VAP was defined according to ECDC criteria. Primary endpoints were VAP incidence density (per 1000 ventilation-days) and 30-day attributable mortality. Secondary endpoints included resistance patterns and pre-pandemic versus pandemic trends.
Results
Among 98,047 patients, 12,251 patients developed VAP, with an incidence of 18.9/1000 ventilation-days. Peak incidence occurred at day 10 (29/1000 ventilation-days). Thirty-day attributable mortality was 4.9% [95% CI 3.7;6.2], rising to 7.2% [6.0;8.5] at 60 days. Gram-negative bacteria accounted for 78.0% of isolates, predominantly Enterobacterales (46%) and Pseudomonas aeruginosa (20%). Third-generation cephalosporin resistance reached 27% in Enterobacterales and 25% in P. aeruginosa . The COVID-19 patients had a higher VAP rate (19.5% vs 9.7%, p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Public Health, Epidemiology & Evolutionary Ecology of Infectious Diseases (PHE3ID) Team, Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernard Lyon…
- Département d'Anesthésie Réanimation, Hospices Civils de Lyon, Lyon, France.
- REA-REZO Infections and Antimicrobial Resistance in Intensive Care, Lyon, France.
- Prévention et Contrôle de l'Infection, Hospices Civils de Lyon, Lyon, France.
- MSD France, Puteaux, France.
- Service Hygiène, Epidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon, Lyon, France.
ORCID-Profile: Charles Hervé Vacheron
Förderung
- Merck Sharp and Dohme France
Zitieren
APA
Vacheron, C. H., Friggeri, A., Machut, A., Prevot, C., Bourge, X., Savey, A., Elias, C., & Lepape, A. (2026). Bacterial epidemiology and attributable mortality of Ventilator-associated pneumonia before and after COVID-19 pandemic (2018-2021). Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666261490896
Vancouver
Vacheron CH, Friggeri A, Machut A, Prevot C, Bourge X, Savey A, et al. Bacterial epidemiology and attributable mortality of Ventilator-associated pneumonia before and after COVID-19 pandemic (2018-2021). Journal of Intensive Care Medicine. 2026. doi:10.1177/08850666261490896
BibTeX
@article{Vacheron2026,
author = {Vacheron, Charles Hervé and Friggeri, Arnaud and Machut, Anaïs and Prevot, Claire and Bourge, Xavier and Savey, Anne and Elias, Christelle and Lepape, Alain},
title = {Bacterial epidemiology and attributable mortality of Ventilator-associated pneumonia before and after COVID-19 pandemic (2018-2021)},
journal = {Journal of Intensive Care Medicine},
year = {2026},
doi = {10.1177/08850666261490896}
}
EUVIMED